Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Brill et al v. Invivyd, Inc et al
Case Number:
1:23-cv-10254
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
September 18, 2024
Biotech Co. Escapes Stock-Drop Suit Over COVID-19 Drug
A Massachusetts biotech company won dismissal Wednesday from a proposed class action by investors who say their shares tanked in value after it allegedly came to light that executives had falsely touted an unproven prospective COVID-19 medicine.
-
April 18, 2023
2 Firms Vie To Lead Investor Suit Over Co.'s COVID Claims
Robbins Geller Rudman & Dowd LLP and Johnson Fistel LLP seek to jointly lead a proposed class action accusing executives of a biotech company of making empty boasts about the ability of its COVID-19 vaccine to fight the Omicron variant to inflate the stock price.
-
January 31, 2023
Biotech Goosed Stock With Omicron Vax Claims, Suit Says
An investor in the biotech company formerly known as Adagio Therapeutics Inc. filed suit Monday in Boston federal court, claiming executives made empty boasts about its COVID-19 vaccine and caused the stock price to tank after the results showed the drug didn't work against the Omicron variant.